The Daily29 Des 2024

The Sunday Read: ‘Ozempic Could Crush the Junk Food Industry. But It Is Fighting Back.’

For decades, Big Food has been marketing products to people who can’t seem to stop eating, and now, suddenly, they can. The active ingredient in new drugs like Ozempic, Wegovy and Zepbound mimics a natural hormone that slows digestion and signals fullness to the brain.

Around seven million Americans take these drugs, but estimates from Morgan Stanley suggest that number could increase to 24 million within the next decade. More than 100 million American adults are obese, and the drugs may eventually be rolled out to people who don’t have diabetes or obesity, as they seem to tame addictions beyond food — appearing to make cocaine, alcohol and cigarettes more resistible. Research is at an early stage, but the drugs may also cut the risk of stroke, heart and kidney disease, Alzheimer’s and Parkinson’s.

Major food companies are scrambling to research the impact of the drugs on their brands — and figure out how to adjust. But for Mattson, which has invented products for the nation’s biggest food conglomerates for nearly 50 years, the Ozempic threat could be a boon.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(2970)

‘Buy Now, Pay Later’: A New Wave of Consumer Debt

As people in the United States struggle with rising costs, they are increasingly turning to “buy now, pay later” loans for essentials such as rent and groceries.Stacey Cowley, a business reporter for ...

8 Sep 24min

Classical Music Is in Crisis. Gustavo Dudamel Is Here to Save It.

This week marks the start of the Gustavo Dudamel era in New York.The superstar conductor was just 28 when he became the musical director of the Los Angeles Philharmonic in 2009. A native of Venezuela ...

6 Sep 42min

The Intertwined Legacies of Gloria Steinem and Dolly Parton

Gloria Steinem, the feminist icon and co-founder of Ms. magazine, died on Wednesday at her home in Manhattan. Her death came as many were still grieving the loss of another iconic woman: Dolly Parton....

4 Sep 30min

A.I. Is Outsmarting Its Creators

From the start, the greatest fear for those developing artificial intelligence was that their creations would go rogue to act in unauthorized and dangerous ways. Some researchers now say it has happen...

3 Sep 40min

The Fight for the West Bank

Over the past year, there has been an increase in violence in the West Bank. Israeli settlers have terrorized Palestinians, set fire to their property, uprooted their olive groves and stolen their ani...

2 Sep 28min

How a Teenager Found Undiagnosed Brain Injuries in the Military

Warning: this episode contains mentions of suicide. New reporting has found that the impact of rough sea waves on rescue-boat crews in the Coast Guard can lead to long-term effects, including traumati...

1 Sep 38min

How Flock Cameras Took Over America

This summer, Fernando Alfonso, the Texas editor for The New York Times, got in a car with a man named Philip. They drove around the suburban streets of Dallas searching for traffic cameras — not for a...

31 Aug 29min

Who Will Rule the 2026 U.S. Open?

The U.S. Open, the final tournament of the tennis season, is getting underway. The world’s best players are heading to the U.S.T.A. Billie Jean King National Tennis Center in Queens, N.Y., to battle i...

30 Aug 38min